Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: VITRIVAX, INC.
Awarding agency: Department of Defense / Defense Threat Reduction Agency
Funding agency: Department of Defense / Defense Threat Reduction Agency
Period of performance: 2023-01-12 to 2024-01-11
Current total value of award: $5858328.98
Description: OPTIMIZATION AND PRODUCTION OF SINGLE-SHOT VACCINES FOR MELIOIDOSIS AND GLANDERS